Lyka Labs informs about statement of investor complaints

11 Jan 2018 Evaluate

Lyka Labs has informed that the Company has not received any complaints in respect of its Listed Securities i.e. shares during the quarter ended 31st December, 2017.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

44.74 -1.78 (-3.83%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×